Blood test could revolutionize esophageal cancer care
NCT ID NCT05704530
First seen Jun 03, 2026 · Last updated Jun 14, 2026 · Updated 3 times
Summary
This study looks at whether a blood test that detects tiny bits of tumor DNA can help doctors better stage esophageal cancer and predict if it will come back after treatment. About 248 adults with resectable esophageal cancer will give blood samples before, during, and after their standard care. The goal is to see if this test can guide more personalized treatment decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AZ Delta
RECRUITINGRoeselare, Belgium
Contact
Contact
-
UZ Gent
RECRUITINGGhent, Belgium
Contact
-
UZA
RECRUITINGAntwerp, Belgium
Contact
-
UZLeuven
RECRUITINGLeuven, Belgium
Contact
Contact
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.